These results, together with a past report exhibiting that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two support the principle of focusing on ACKR3 as a novel strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant Diseases. Be aware: Results could https://cicerog826srm7.blogsuperapp.com/profile